Columbia University Irving Medical Center (CUIMC)

Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis (2024) Vukadinovic D, Lauder L, Kandzari DE, Bhatt DL, Kirtane AJ, Edelman ER, Schmieder R, et al. Journal article Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD (2024) Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al. Journal article The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants (2024) Furia F, Levy AM, Theunis M, Bamshad MJ, Bartos MN, Bijlsma EK, Brancati F, et al. Journal article International consensus on the management of large (≥20 mm) colorectal laterally spreading tumors: World Endoscopy Organization Delphi study (2024) Djinbachian R, Rex DK, Chiu HM, Fukami N, Aihara H, Bastiaansen BA, Bechara R, et al. Journal article Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z) (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article, Erratum Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. (2024) Akahoshi Y, Spyrou N, Hoepting M, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al. Journal article A Day 14 Endpoint for Acute GVHD Clinical Trials (2024) Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Al Malki MM, et al. Journal article Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition (2023) Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, Easton A, et al. Journal article, Review article Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023) Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al. Journal article